ArticlePolymers2026
Surface-Exposed Hydroxyapatite Microparticles in Electrospun PLLA Scaffolds: Mechanical Reinforcement and Osteogenic Response.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The addition of hydroxyapatite (HAP) to electrospun poly-L-lactide (PLLA) scaffolds promotes cell adhesion and differentiation but generally leads to a significant deterioration in mechanical properties due to particle agglomeration. Moreover, the encapsulation of HAP particles within a polymer layer makes them inaccessible to body fluids and cells, thereby limiting the bioactivity of the resulting composite scaffold. In this work, HAP microparticles with median size of 26.3 µm were used to obtain exposed HAP particles on the surface of electrospun PLLA fibers. SEM images and EDX maps revealed that individual particles, particularly the larger ones, were exposed from the polymer scaffold surface. The addition of HAP particles significantly altered the scaffold morphology and structure, increasing the fiber diameter and surface roughness by 2.8-4.1-fold, promoting the formation of fused fiber junctions, and inducing the appearance of semicrystalline PLLA domains. These structural changes significantly improved the mechanical properties of the scaffolds. Specifically, the tensile strength and Young's modulus of the prepared scaffolds are increased by 2.3-3.8-fold following HAP incorporation. Compared with neat PLLA scaffolds, HAP-containing scaffolds exhibited 1.2-1.4-fold higher osteocalcin and osteopontin expression by human adipose-derived mesenchymal stromal cells (hADSCs). Compared to tissue culture plastic, the expressions of osteocalcin and osteopontin on the composite scaffolds were 7.1-7.9-fold and 2.8-3.0-fold higher, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.